看來載入頁面時發生了錯誤.
我們的團隊已收到通知，但若此問題持續，請透過電郵支援widget工具聯絡我們。
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM P/E Multiple | -4.4x - -4.8x | -4.6x |
| Selected Fwd P/E Multiple | -0.2x - -0.3x | -0.3x |
| Fair Value | ₩520.44 - ₩575.22 | ₩547.83 |
| Upside | -17.4% - -8.7% | -13.0% |
| Benchmarks | - | Full Ticker |
| Cell Bio Human Tech Co.,Ltd | - | KOSDAQ:A318160 |
| Jeonjinbio Co., Ltd. | - | KOSDAQ:A110020 |
| SH Energy & Chemical Co., Ltd. | - | KOSE:A002360 |
| KNW Co., Ltd. | - | KOSDAQ:A105330 |
| Daejung Chemicals & Metals Co., Ltd. | - | KOSDAQ:A120240 |
| Nano Chem Tech Inc. | - | KOSDAQ:A091970 |
| - | - | - |
| Select Price / LTM EPS Ratio | ||||||||
| Benchmark Companies | ||||||||
| A318160 | A110020 | A002360 | A105330 | A120240 | A091970 | |||
| KOSDAQ:A318160 | KOSDAQ:A110020 | KOSE:A002360 | KOSDAQ:A105330 | KOSDAQ:A120240 | KOSDAQ:A091970 | |||
| Historical Net Income Growth | ||||||||
| 5Y CAGR | 1.5% | NM- | NM- | NM- | 9.8% | NM- | ||
| 3Y CAGR | 11.8% | NM- | NM- | -25.5% | 4.7% | NM- | ||
| Latest Twelve Months | 335.8% | 167.5% | -303.7% | 67.7% | -25.3% | 18.3% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | 4.8% | -45.2% | -2.7% | 0.7% | 11.4% | -24.2% | ||
| Prior Fiscal Year | -6.8% | -41.1% | -1.9% | 2.2% | 13.9% | -10.7% | ||
| Latest Fiscal Year | 15.4% | 22.6% | -8.3% | 4.4% | 10.5% | -6.7% | ||
| Latest Twelve Months | 15.4% | 22.6% | -8.3% | 4.4% | 10.5% | -6.7% | ||
| Current Trading Multiples | ||||||||
| EV / LTM EBITDA | 6.7x | 6.5x | -4.3x | 13.7x | 1.5x | 17.2x | ||
| Price / LTM Sales | 1.8x | 1.2x | 0.4x | 0.8x | 1.0x | 0.4x | ||
| LTM P/E Ratio | 11.5x | 5.3x | -4.7x | 19.1x | 9.4x | -6.1x | ||
| Low | Mid | High | ||||||
| Benchmark LTM P/E Ratio | -4.7x | 9.4x | 19.1x | |||||
| Historical LTM P/E Ratio | -6.1x | -3.2x | -2.8x | |||||
| Selected P/E Multiple | -4.4x | -4.6x | -4.8x | |||||
| (x) LTM Net Income | (3,721) | (3,721) | (3,721) | |||||
| (=) Equity Value | 16,265 | 17,121 | 17,977 | |||||
| (/) Shares Outstanding | 36.1 | 36.1 | 36.1 | |||||
| Implied Value Range | 450.05 | 473.74 | 497.42 | |||||
| FX Rate: KRW/KRW | 1.0 | 1.0 | 1.0 | Market Price | ||||
| Implied Value Range (Trading Cur) | 450.05 | 473.74 | 497.42 | 630.00 | ||||
| Upside / (Downside) | -28.6% | -24.8% | -21.0% | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | A318160 | A110020 | A002360 | A105330 | A120240 | A091970 | |
| Value of Common Equity | 50,395 | 22,919 | 48,525 | 65,862 | 90,599 | 22,768 | |
| (/) Shares Outstanding | 8.3 | 9.1 | 108.8 | 15.9 | 7.2 | 36.1 | |
| Implied Stock Price | 6,060.00 | 2,530.00 | 446.00 | 4,150.00 | 12,600.00 | 630.00 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 6,060.00 | 2,530.00 | 446.00 | 4,150.00 | 12,600.00 | 630.00 | |
| Trading Currency | KRW | KRW | KRW | KRW | KRW | KRW | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |